3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
2
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Endocrine
2
Conditions
Pheochromocytoma
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Adrenocortical Adenoma
1
Adrenal incidentaloma
1
Interventions
lutetium Lu 177 dotatate
30
Magnetic Resonance Spectroscopy
25
pembrolizumab
21
Specimen Handling
18
Nivolumab
17
cabozantinib
14
lenvatinib
12
Everolimus
12
trametinib
11
gallium Ga 68 dotatate
10
dabrafenib
10
Ipilimumab
10
Carboplatin
10
Cisplatin
8
atezolizumab
7
Temozolomide
7
Lutetium-177
7
X-Rays
6
Etoposide
6
Capecitabine
6
surufatinib
5
lanreotide
5
fluorodopa F 18
5
cemiplimab
5
Vemurafenib
5
Paclitaxel
5
Octreotide
5
Lutetium
5
Fluorodeoxyglucose F18
5
Disulfides
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Adrenalectomy
×
Endocrine
×
1 year
×
Clear all
NCT07470580
2026-03-13
ADERADHTA2
University Hospital, Toulouse
Phase NA
Not yet recruiting
134 enrolled
NCT07200245
2025-10-01
HEMODYNAMICS
Central Hospital, Nancy, France
Not yet recruiting
522 enrolled